PROTEIN KINASE A (PKA) SIGNALING PATHWAY (PW:0000543)
Description
Protein
kinase A (PKA) signaling is a widely used intracellular pathway and the major route for channeling the second messenger cAMP signal.
Ligand activated G-protein coupled receptors that transduce the signal via the
Gs alpha subunit of the heterotrimeric G protein lead to activation of the adenylyl
cyclase enzymes (AC) that catalyze the formation of cAMP from ATP. GTP-bound Gs
binds to AC and increases the affinity between the C1 and C2 cytoplasmic
domains whose interface constitutes the ATP binding site. Nine membrane-bound
and one soluble adenylyl cyclase have been so far identified. Most tissues
express more than one AC and almost every AC is expressed in the brain. cAMP
binding to the PKA complex leads to dissociation of the catalytic subunits from
the holoenzyme. In the inactive state, the holoenzyme consists of two catalytic
subunits (C) bound noncovalently to a regulatory dimer (RI or RII). There are two
type I and two type II regulatory subunits and three catalytic subunits in
humans; rodents express only two catalytic subunits. Each regulatory subunit
has two cAMP binding sites; type I has a higher affinity for cAMP than type II.
Binding of four molecules of cAMP to the regulatory dimer induces a
conformational change that leads to dissociation of the holoenzyme and release
of the catalytic monomers. cAMP is hydrolyzed by phosphodiesterases (PDE), the
only enzymes degrading cycling nucleotides. The 21 mammalian genes are
subdivided in 11 families based on kinetic and pharmacological properties. Of these,
3 families are specific for cAMP, 3 other for cGMP and 5 hydrolyze both. PDEs not
only contribute to the regulation of cAMP concentration but also modulate the
duration and extent of cAMP signaling, and thus of PKA. The compartmentalization
of PKA is mediated by the AKAP family of scaffold proteins (
A K inase
A nchoring
P rotein). AKAPs bring together PKA (and other kinases)
along with phosphatases and phosphodiesterases, in some cases AC and target
proteins to fine tune the many outcomes of PKA signaling. 14 Akap genes in
mammals give rise to more than 50 proteins. Primarily they target the regulatory
type II subunits; a few possess dual specificity and bind both subunits types.
The various combinations of AKAP-PKA allow for the diversity of cellular and
tissue distribution of the serine/threonine PKA complexes and the modulation of
their function and underlie the extensive use of this intracellular pathway.
PKA cross-talks or integrates with other signaling pathways. The PKA signaling
pathway has been implicated in many cellular and physiological processes, from
metabolism and reproduction, to cardiac function, memory and learning.
To see the ontology report for annotations,
GViewer and download click here [click to see the ontology report for related GO
term GO:0010737 and entry at Reactome - REACT_15530.1 ]...(less)
Pathway Diagram:
Genes in Pathway:
G
Adcy1
adenylate cyclase 1
ISO
RGD
PMID:18948702
RGD:2312469
NCBI chr14:86,125,119...86,234,459
Ensembl chr14:86,124,850...86,261,075
G
Adcy10
adenylate cyclase 10
ISO
RGD
PMID:18948702
RGD:2312469
NCBI chr13:80,280,595...80,366,939
Ensembl chr13:80,284,295...80,366,926
G
Adcy2
adenylate cyclase 2
ISO
RGD
PMID:18948702
RGD:2312469
NCBI chr 1:36,204,054...36,650,645
Ensembl chr 1:36,204,054...36,650,645
G
Adcy3
adenylate cyclase 3
ISO
RGD
PMID:18948702
RGD:2312469
NCBI chr 6:32,819,602...32,923,174
Ensembl chr 6:32,843,961...32,923,173
G
Adcy4
adenylate cyclase 4
ISO
RGD
PMID:18948702
RGD:2312469
NCBI chr15:33,236,201...33,252,070
Ensembl chr15:33,236,208...33,252,026
G
Adcy5
adenylate cyclase 5
ISO
RGD
PMID:18948702
RGD:2312469
NCBI chr11:78,976,861...79,123,343
Ensembl chr11:78,976,861...79,123,343
G
Adcy6
adenylate cyclase 6
ISO IDA
RGD
PMID:18948702 PMID:15579502
RGD:2312469 , RGD:2313211
NCBI chr 7:131,621,860...131,642,923
Ensembl chr 7:131,621,860...131,642,770
G
Adcy7
adenylate cyclase 7
ISO
RGD
PMID:18948702
RGD:2312469
NCBI chr19:34,913,154...34,972,366
Ensembl chr19:34,914,322...34,936,743
G
Adcy8
adenylate cyclase 8
ISO
RGD
PMID:18948702
RGD:2312469
NCBI chr 7:98,306,434...98,555,687
Ensembl chr 7:98,306,464...98,555,038
G
Adcy9
adenylate cyclase 9
ISO
RGD
PMID:18948702
RGD:2312469
NCBI chr10:11,645,373...11,768,462
Ensembl chr10:11,645,282...11,765,792
G
Akap1
A-kinase anchoring protein 1
ISO
RGD
PMID:14715913 PMID:19319965
RGD:2312475 , RGD:2312477
NCBI chr10:74,118,232...74,151,366
Ensembl chr10:74,119,124...74,138,190
G
Akap10
A-kinase anchoring protein 10
ISO
RGD
PMID:14715913 PMID:19319965
RGD:2312475 , RGD:2312477
NCBI chr10:47,044,819...47,108,153
Ensembl chr10:47,044,819...47,108,203
G
Akap11
A-kinase anchoring protein 11
ISO IMP
RGD
PMID:14715913 PMID:19319965 PMID:18385542
RGD:2312475 , RGD:2312477 , RGD:2312637
NCBI chr15:60,320,839...60,365,480
Ensembl chr15:60,320,839...60,365,335
G
Akap12
A-kinase anchoring protein 12
ISO
RGD
PMID:14715913 PMID:19319965
RGD:2312475 , RGD:2312477
NCBI chr 1:43,135,515...43,225,245
Ensembl chr 1:43,199,008...43,225,557
G
Akap13
A-kinase anchoring protein 13
ISO
RGD
PMID:14715913 PMID:19319965
RGD:2312475 , RGD:2312477
NCBI chr 1:138,722,445...139,029,401
Ensembl chr 1:138,724,150...139,029,401
G
Akap14
A-kinase anchoring protein 14
ISO
RGD
PMID:14715913 PMID:19319965
RGD:2312475 , RGD:2312477
NCBI chr X:121,261,195...121,276,376
Ensembl chr X:121,259,899...121,276,376
G
Akap3
A-kinase anchoring protein 3
ISO
RGD
PMID:14715913 PMID:19319965
RGD:2312475 , RGD:2312477
NCBI chr 4:161,374,198...161,400,062
Ensembl chr 4:161,374,407...161,400,230
G
Akap4
A-kinase anchoring protein 4
ISO
RGD
PMID:14715913 PMID:19319965
RGD:2312475 , RGD:2312477
NCBI chr X:18,107,256...18,117,549
Ensembl chr X:18,107,275...18,117,549
G
Akap5
A-kinase anchoring protein 5
ISO
RGD
PMID:14715913 PMID:19319965
RGD:2312475 , RGD:2312477
NCBI chr 6:100,787,169...100,796,712
Ensembl chr 6:100,790,148...100,796,620
G
Akap6
A-kinase anchoring protein 6
ISO IMP
RGD
PMID:14715913 PMID:19319965 PMID:11296225
RGD:2312475 , RGD:2312477 , RGD:68716
NCBI chr 6:75,919,350...76,359,667
Ensembl chr 6:75,919,513...76,355,036
G
Akap7
A-kinase anchoring protein 7
ISO IMP
RGD
PMID:14715913 PMID:19319965 PMID:17901878
RGD:2312475 , RGD:2312477 , RGD:2312630
NCBI chr 1:21,906,503...22,168,663
Ensembl chr 1:21,906,676...22,037,090
G
Akap8
A-kinase anchoring protein 8
ISO
RGD
PMID:14715913 PMID:19319965
RGD:2312475 , RGD:2312477
NCBI chr 7:11,966,769...11,983,056
Ensembl chr 7:11,966,772...11,982,900
G
Akap9
A-kinase anchoring protein 9
ISO
RGD
PMID:14715913 PMID:19319965
RGD:2312475 , RGD:2312477
NCBI chr 4:31,011,475...31,147,338
Ensembl chr 4:31,011,475...31,147,338
G
Crhr2
corticotropin releasing hormone receptor 2
IMP
RGD
PMID:15911134
RGD:5131271
NCBI chr 4:85,553,163...85,596,203
Ensembl chr 4:85,554,268...85,596,318
G
Ezr
ezrin
ISO
RGD
PMID:14715913
RGD:2312475
NCBI chr 1:49,373,033...49,416,573
Ensembl chr 1:49,373,035...49,416,573
G
Glp1r
glucagon-like peptide 1 receptor
IMP
RGD
PMID:10446905
RGD:1598448
NCBI chr20:8,973,393...9,011,622
Ensembl chr20:8,973,352...9,011,654
G
Pakap
paralemmin A kinase anchor protein
ISO
RGD
PMID:14715913 PMID:19319965
RGD:2312475 , RGD:2312477
NCBI chr 5:76,976,906...77,443,656
Ensembl chr 5:76,977,112...77,443,656
G
Pde10a
phosphodiesterase 10A
ISO
RGD
PMID:17376027
RGD:2312479
NCBI chr 1:54,313,343...54,765,668
Ensembl chr 1:54,317,732...54,764,051
G
Pde11a
phosphodiesterase 11A
ISO
RGD
PMID:17376027
RGD:2312479
NCBI chr 3:81,320,822...81,704,397
Ensembl chr 3:81,320,822...81,680,612
G
Pde1a
phosphodiesterase 1A
ISO
RGD
PMID:17376027
RGD:2312479
NCBI chr 3:85,152,053...85,432,289
Ensembl chr 3:85,154,184...85,519,212
G
Pde1b
phosphodiesterase 1B
ISO
RGD
PMID:17376027
RGD:2312479
NCBI chr 7:136,505,834...136,533,034
Ensembl chr 7:136,505,689...136,533,033
G
Pde1c
phosphodiesterase 1C
ISO
RGD
PMID:17376027
RGD:2312479
NCBI chr 4:86,629,074...87,108,147
Ensembl chr 4:86,626,282...87,193,259
G
Pde2a
phosphodiesterase 2A
ISO
RGD
PMID:17376027
RGD:2312479
NCBI chr 1:165,235,623...165,327,466
Ensembl chr 1:165,235,623...165,327,466
G
Pde3a
phosphodiesterase 3A
ISO
RGD
PMID:17376027 PMID:17376027
RGD:2312479 , RGD:2312479
NCBI chr 4:175,904,276...176,170,531
Ensembl chr 4:175,904,077...176,169,270
G
Pde3b
phosphodiesterase 3B
ISO
RGD
PMID:17376027
RGD:2312479
NCBI chr 1:178,041,207...178,204,503
Ensembl chr 1:178,041,207...178,204,503
G
Pde4a
phosphodiesterase 4A
ISO
RGD
PMID:17376027
RGD:2312479
NCBI chr 8:27,966,978...28,029,721
Ensembl chr 8:27,966,996...28,046,924
G
Pde4b
phosphodiesterase 4B
ISO
RGD
PMID:17376027
RGD:2312479
NCBI chr 5:122,028,956...122,598,267
Ensembl chr 5:122,135,174...122,598,267
G
Pde4c
phosphodiesterase 4C
ISO
RGD
PMID:17376027
RGD:2312479
NCBI chr16:18,724,703...18,745,528
Ensembl chr16:18,725,674...18,744,037
G
Pde4d
phosphodiesterase 4D
ISO IMP
RGD
PMID:17376027 PMID:11296225
RGD:2312479 , RGD:68716
NCBI chr 2:41,748,337...43,262,567
Ensembl chr 2:42,110,838...43,262,569
G
Pde7a
phosphodiesterase 7A
ISO
RGD
PMID:17376027
RGD:2312479
NCBI chr 2:103,631,655...103,723,057
Ensembl chr 2:103,634,594...103,722,890
G
Pde7b
phosphodiesterase 7B
ISO
RGD
PMID:17376027
RGD:2312479
NCBI chr 1:16,994,072...17,312,828
Ensembl chr 1:17,002,286...17,312,456
G
Pde8a
phosphodiesterase 8A
ISO
RGD
PMID:17376027
RGD:2312479
NCBI chr 1:144,575,203...144,698,216
Ensembl chr 1:144,575,428...144,698,215
G
Pde8b
phosphodiesterase 8B
ISO
RGD
PMID:17376027
RGD:2312479
NCBI chr 2:28,009,841...28,244,050
Ensembl chr 2:28,011,359...28,244,327
G
Prkaca
protein kinase cAMP-activated catalytic subunit alpha
ISO
RGD
PMID:14715913
RGD:2312475
NCBI chr19:41,059,843...41,083,189
Ensembl chr19:41,059,843...41,086,494
G
Prkacb
protein kinase cAMP-activated catalytic subunit beta
ISO
RGD
PMID:14715913
RGD:2312475
NCBI chr 2:238,297,140...238,389,317
Ensembl chr 2:238,300,127...238,386,315
G
Prkar1a
protein kinase cAMP-dependent type I regulatory subunit alpha
ISO
RGD
PMID:14715913
RGD:2312475
NCBI chr10:95,120,537...95,139,028
Ensembl chr10:95,120,487...95,139,025
G
Prkar1b
protein kinase cAMP-dependent type I regulatory subunit beta
ISO
RGD
PMID:14715913
RGD:2312475
NCBI chr12:20,606,066...20,738,766
Ensembl chr12:20,618,757...20,738,766
G
Prkar2a
protein kinase cAMP-dependent type II regulatory subunit alpha
ISO
RGD
PMID:14715913
RGD:2312475
NCBI chr 8:118,271,608...118,337,332
Ensembl chr 8:118,274,167...118,337,330
G
Prkar2b
protein kinase cAMP-dependent type II regulatory subunit beta
ISO
RGD
PMID:14715913
RGD:2312475
NCBI chr 6:54,291,143...54,381,639
Ensembl chr 6:54,291,151...54,381,411
Pathway Gene Annotations
Disease Annotations Associated with Genes in the protein kinase A (PKA) signaling pathway
Adcy1 autosomal recessive nonsyndromic deafness 44 , genetic disease , Hyperkinesis , lung small cell carcinoma , withdrawal disorder Adcy10 Cardiomegaly , Hypercalciuria, Absorptive, 2 , Optic Nerve Injuries Adcy2 asthma , bipolar disorder Adcy3 cardiomyopathy , diabetes mellitus , diabetic angiopathy , genetic disease , major depressive disorder , morbid obesity , obesity , Spinal Cord Injuries Adcy5 Animal Mammary Neoplasms , Birth Weight , carcinoma , cardiomyopathy , distal myopathy 4 , Dyskinesia with Orofacial Involvement , Dyskinesia with Orofacial Involvement, Autosomal Dominant , Dyskinesia with Orofacial Involvement, Autosomal Recessive , Experimental Mammary Neoplasms , Fibrosis , genetic disease , hypertension , language disorder , left ventricular failure , NEURODEVELOPMENTAL DISORDER WITH HYPERKINETIC MOVEMENTS AND DYSKINESIA , Neurodevelopmental Disorders , osteoporosis , Parkinson's disease , type 2 diabetes mellitus Adcy6 genetic disease , Lethal Congenital Contracture Syndrome 8 , ureteral obstruction Adcy7 acute myeloid leukemia , juvenile rheumatoid arthritis , schizophrenia , ulcerative colitis Adcy8 diabetic angiopathy , Hyperkinesis , mood disorder , withdrawal disorder Adcy9 mood disorder , Neurodevelopmental Disorders , Rubinstein-Taybi syndrome Akap1 brain ischemia , obesity , prostate cancer Akap10 Heart Block , sudden infant death syndrome Akap11 bipolar disorder , Mouth Neoplasms , schizophrenia Akap12 Acute Lung Injury , brain ischemia , Breast Neoplasms , chronic kidney disease , colorectal carcinoma , COVID-19 , Experimental Autoimmune Encephalomyelitis , Inflammation , juvenile myelomonocytic leukemia , liver cirrhosis , osteosarcoma , sciatic neuropathy Akap13 Esophageal Neoplasms , Prostatic Neoplasms , renal cell carcinoma Akap3 spermatogenic failure 82 Akap4 Asthenozoospermia , male infertility , Teratozoospermia Akap5 Alzheimer's disease , Cardiomegaly , COVID-19 , developmental coordination disorder , Memory Disorders , Tetany Akap6 anorexia nervosa , atrial fibrillation , congestive heart failure , Duchenne muscular dystrophy , hypertrophic cardiomyopathy , ovary epithelial cancer Akap7 substance-related disorder Akap8 long QT syndrome Akap9 amyloidosis , arrhythmogenic right ventricular cardiomyopathy , Arsenic Poisoning , atrial fibrillation , Brugada syndrome , Brugada syndrome 1 , cardiac arrest , Cardiac Arrhythmias , cardiomyopathy , catecholaminergic polymorphic ventricular tachycardia , colorectal cancer , congestive heart failure , dilated cardiomyopathy , hypertrophic cardiomyopathy , long QT syndrome , long QT syndrome 1 , long QT syndrome 11 , long QT syndrome 2 , restrictive cardiomyopathy , Romano-Ward Syndrome , skin disease , Sudden Cardiac Death , Sudden Unexpected Nocturnal Death Syndrome , Ventricular Fibrillation , Ventricular Tachycardia , Wolff-Parkinson-White syndrome Crhr2 alcohol use disorder , Anorexia , anxiety disorder , asthma , Cocaine-Related Disorders , colitis , depressive disorder , Fetal Hypoxia , functional colonic disease , hypertension , Hypotension , Inflammation , irritable bowel syndrome , ischemia , Left Ventricular Hypertrophy , lung disease , muscular atrophy , Pneumococcal Pneumonia , pneumonia , rhinitis Ezr Animal Mammary Neoplasms , carcinoma , Experimental Liver Cirrhosis , Experimental Mammary Neoplasms , Neoplasm Metastasis , osteoarthritis , Prostatic Neoplasms Glp1r diabetes mellitus , disease of cellular proliferation , Experimental Diabetes Mellitus , glucose intolerance , hyperglycemia , Hyperplasia , hypertension , obesity , status epilepticus , type 2 diabetes mellitus Pakap prostate cancer , Weight Gain Pde10a Developmental Disabilities , genetic disease , Infantile-Onset Limb and Orofacial Dyskinesia , Muscle Hypotonia , striatal degeneration 2 , traumatic brain injury Pde11a Bardet-Biedl syndrome 16 , primary pigmented nodular adrenocortical disease 2 , schizophrenia Pde1a Left Ventricular Hypertrophy Pde1b cerebellar ataxia , learning disability , Parkinsonism Pde1c autosomal dominant nonsyndromic deafness , autosomal dominant nonsyndromic deafness 74 , prostate cancer , substance-related disorder Pde2a Alzheimer's disease , Breast Neoplasms , cardiomyopathy , choreatic disease , dystonia , genetic disease , INTELLECTUAL DEVELOPMENTAL DISORDER WITH PAROXYSMAL DYSKINESIA OR SEIZURES , intellectual disability , Left Ventricular Hypertrophy , Muscle Hypotonia Pde3a Desbuquois dysplasia , Experimental Diabetes Mellitus , genetic disease , hypertension and brachydactyly syndrome , Left Ventricular Hypertrophy , myocardial infarction , obesity , prostate cancer , pulmonary hypertension , stroke , thrombosis Pde3b polycystic ovary syndrome Pde4a autistic disorder , brucellosis , Experimental Seizures Pde4b acute myeloid leukemia , alcohol dependence , alcohol use disorder , amphetamine abuse , Arsenic Poisoning , asthma , autistic disorder , bipolar disorder , Burns , Myocardial Ischemia , schizophrenia , skin disease Pde4d acrodysostosis , Acrodysostosis 2, with or without Hormone Resistance , amphetamine abuse , asthma , Brain Injuries , depressive disorder , Desbuquois dysplasia , esophageal atresia , genetic disease , Nasal Polyps , Prostatic Neoplasms , Spinal Cord Injuries , stroke , transient cerebral ischemia Pde7b prostate cancer Pde8b basal ganglia disease , congenital adrenal hyperplasia , Dysarthria , genetic disease , Muscle Rigidity , Nerve Degeneration , neurodegenerative disease , primary pigmented nodular adrenocortical disease 3 , Striatal Degeneration, Autosomal Dominant , Striatal Degeneration, Autosomal Dominant 1 Prkaca ACTH-independent macronodular adrenal hyperplasia 1 , adrenal cortical adenoma , Adrenal Gland Neoplasms , amphetamine abuse , brain ischemia , Cardioacrofacial Dysplasia 1 , cholangiocarcinoma , congestive heart failure , Desbuquois dysplasia , fibrolamellar carcinoma , Hypoglossal Nerve Injuries , metabolic dysfunction-associated steatotic liver disease , mixed fibrolamellar hepatocellular carcinoma , Neurodevelopmental Disorders , primary pigmented nodular adrenocortical disease 4 Prkacb adrenal cortical adenoma , biliary tract benign neoplasm , brain ischemia , Cardioacrofacial Dysplasia 2 , cholangiocarcinoma , Cushing Syndrome , Desbuquois dysplasia , genetic disease , Hypoglossal Nerve Injuries , Prostatic Neoplasms Prkar1a acrodysostosis , Acrodysostosis 1, with or without Hormone Resistance , acute promyelocytic leukemia , Adrenal Cortex Neoplasms , alopecia , apparent mineralocorticoid excess syndrome , arrhythmogenic right ventricular dysplasia 10 , Carney complex , congenital adrenal hyperplasia , Cushing Syndrome , Desbuquois dysplasia , Familial Atrial Myxoma , follicular thyroid carcinoma , Hereditary Neoplastic Syndromes , hyperglycemia , Insulin Resistance , medulloblastoma , muscular atrophy , Myxoma , obesity , primary pigmented nodular adrenocortical disease , primary pigmented nodular adrenocortical disease 1 Prkar1b hypertension , MARBACH-SCHAAF NEURODEVELOPMENTAL SYNDROME , Neurodevelopmental Disorders , Tremor Prkar2a congestive heart failure Prkar2b congestive heart failure , granulosa cell tumor , obesity
acrodysostosis Pde4d , Prkar1a Acrodysostosis 1, with or without Hormone Resistance Prkar1a Acrodysostosis 2, with or without Hormone Resistance Pde4d ACTH-independent macronodular adrenal hyperplasia 1 Prkaca Acute Lung Injury Akap12 acute myeloid leukemia Adcy7 , Pde4b acute promyelocytic leukemia Prkar1a Adrenal Cortex Neoplasms Prkar1a adrenal cortical adenoma Prkaca , Prkacb Adrenal Gland Neoplasms Prkaca alcohol dependence Pde4b alcohol use disorder Crhr2 , Pde4b alopecia Prkar1a Alzheimer's disease Akap5 , Pde2a amphetamine abuse Pde4b , Pde4d , Prkaca amyloidosis Akap9 Animal Mammary Neoplasms Adcy5 , Ezr Anorexia Crhr2 anorexia nervosa Akap6 anxiety disorder Crhr2 apparent mineralocorticoid excess syndrome Prkar1a arrhythmogenic right ventricular cardiomyopathy Akap9 arrhythmogenic right ventricular dysplasia 10 Prkar1a Arsenic Poisoning Akap9 , Pde4b Asthenozoospermia Akap4 asthma Adcy2 , Crhr2 , Pde4b , Pde4d atrial fibrillation Akap6 , Akap9 autistic disorder Pde4a , Pde4b autosomal dominant nonsyndromic deafness Pde1c autosomal dominant nonsyndromic deafness 74 Pde1c autosomal recessive nonsyndromic deafness 44 Adcy1 Bardet-Biedl syndrome 16 Pde11a basal ganglia disease Pde8b biliary tract benign neoplasm Prkacb bipolar disorder Adcy2 , Akap11 , Pde4b Birth Weight Adcy5 Brain Injuries Pde4d brain ischemia Akap1 , Akap12 , Prkaca , Prkacb Breast Neoplasms Akap12 , Pde2a brucellosis Pde4a Brugada syndrome Akap9 Brugada syndrome 1 Akap9 Burns Pde4b carcinoma Adcy5 , Ezr cardiac arrest Akap9 Cardiac Arrhythmias Akap9 Cardioacrofacial Dysplasia 1 Prkaca Cardioacrofacial Dysplasia 2 Prkacb Cardiomegaly Adcy10 , Akap5 cardiomyopathy Adcy3 , Adcy5 , Akap9 , Pde2a Carney complex Prkar1a catecholaminergic polymorphic ventricular tachycardia Akap9 cerebellar ataxia Pde1b cholangiocarcinoma Prkaca , Prkacb choreatic disease Pde2a chronic kidney disease Akap12 Cocaine-Related Disorders Crhr2 colitis Crhr2 colorectal cancer Akap9 colorectal carcinoma Akap12 congenital adrenal hyperplasia Pde8b , Prkar1a congestive heart failure Akap6 , Akap9 , Prkaca , Prkar2a , Prkar2b COVID-19 Akap12 , Akap5 Cushing Syndrome Prkacb , Prkar1a depressive disorder Crhr2 , Pde4d Desbuquois dysplasia Pde3a , Pde4d , Prkaca , Prkacb , Prkar1a developmental coordination disorder Akap5 Developmental Disabilities Pde10a diabetes mellitus Adcy3 , Glp1r diabetic angiopathy Adcy3 , Adcy8 dilated cardiomyopathy Akap9 disease of cellular proliferation Glp1r distal myopathy 4 Adcy5 Duchenne muscular dystrophy Akap6 Dysarthria Pde8b Dyskinesia with Orofacial Involvement Adcy5 Dyskinesia with Orofacial Involvement, Autosomal Dominant Adcy5 Dyskinesia with Orofacial Involvement, Autosomal Recessive Adcy5 dystonia Pde2a esophageal atresia Pde4d Esophageal Neoplasms Akap13 Experimental Autoimmune Encephalomyelitis Akap12 Experimental Diabetes Mellitus Glp1r , Pde3a Experimental Liver Cirrhosis Ezr Experimental Mammary Neoplasms Adcy5 , Ezr Experimental Seizures Pde4a Familial Atrial Myxoma Prkar1a Fetal Hypoxia Crhr2 fibrolamellar carcinoma Prkaca Fibrosis Adcy5 follicular thyroid carcinoma Prkar1a functional colonic disease Crhr2 genetic disease Adcy1 , Adcy3 , Adcy5 , Adcy6 , Pde10a , Pde2a , Pde3a , Pde4d , Pde8b , Prkacb glucose intolerance Glp1r granulosa cell tumor Prkar2b Heart Block Akap10 Hereditary Neoplastic Syndromes Prkar1a Hypercalciuria, Absorptive, 2 Adcy10 hyperglycemia Glp1r , Prkar1a Hyperkinesis Adcy1 , Adcy8 Hyperplasia Glp1r hypertension Adcy5 , Crhr2 , Glp1r , Prkar1b hypertension and brachydactyly syndrome Pde3a hypertrophic cardiomyopathy Akap6 , Akap9 Hypoglossal Nerve Injuries Prkaca , Prkacb Hypotension Crhr2 Infantile-Onset Limb and Orofacial Dyskinesia Pde10a Inflammation Akap12 , Crhr2 Insulin Resistance Prkar1a INTELLECTUAL DEVELOPMENTAL DISORDER WITH PAROXYSMAL DYSKINESIA OR SEIZURES Pde2a intellectual disability Pde2a irritable bowel syndrome Crhr2 ischemia Crhr2 juvenile myelomonocytic leukemia Akap12 juvenile rheumatoid arthritis Adcy7 language disorder Adcy5 learning disability Pde1b left ventricular failure Adcy5 Left Ventricular Hypertrophy Crhr2 , Pde1a , Pde2a , Pde3a Lethal Congenital Contracture Syndrome 8 Adcy6 liver cirrhosis Akap12 long QT syndrome Akap8 , Akap9 long QT syndrome 1 Akap9 long QT syndrome 11 Akap9 long QT syndrome 2 Akap9 lung disease Crhr2 lung small cell carcinoma Adcy1 major depressive disorder Adcy3 male infertility Akap4 MARBACH-SCHAAF NEURODEVELOPMENTAL SYNDROME Prkar1b medulloblastoma Prkar1a Memory Disorders Akap5 metabolic dysfunction-associated steatotic liver disease Prkaca mixed fibrolamellar hepatocellular carcinoma Prkaca mood disorder Adcy8 , Adcy9 morbid obesity Adcy3 Mouth Neoplasms Akap11 Muscle Hypotonia Pde10a , Pde2a Muscle Rigidity Pde8b muscular atrophy Crhr2 , Prkar1a myocardial infarction Pde3a Myocardial Ischemia Pde4b Myxoma Prkar1a Nasal Polyps Pde4d Neoplasm Metastasis Ezr Nerve Degeneration Pde8b neurodegenerative disease Pde8b NEURODEVELOPMENTAL DISORDER WITH HYPERKINETIC MOVEMENTS AND DYSKINESIA Adcy5 Neurodevelopmental Disorders Adcy5 , Adcy9 , Prkaca , Prkar1b obesity Adcy3 , Akap1 , Glp1r , Pde3a , Prkar1a , Prkar2b Optic Nerve Injuries Adcy10 osteoarthritis Ezr osteoporosis Adcy5 osteosarcoma Akap12 ovary epithelial cancer Akap6 Parkinson's disease Adcy5 Parkinsonism Pde1b Pneumococcal Pneumonia Crhr2 pneumonia Crhr2 polycystic ovary syndrome Pde3b primary pigmented nodular adrenocortical disease Prkar1a primary pigmented nodular adrenocortical disease 1 Prkar1a primary pigmented nodular adrenocortical disease 2 Pde11a primary pigmented nodular adrenocortical disease 3 Pde8b primary pigmented nodular adrenocortical disease 4 Prkaca prostate cancer Akap1 , Pakap , Pde1c , Pde3a , Pde7b Prostatic Neoplasms Akap13 , Ezr , Pde4d , Prkacb pulmonary hypertension Pde3a renal cell carcinoma Akap13 restrictive cardiomyopathy Akap9 rhinitis Crhr2 Romano-Ward Syndrome Akap9 Rubinstein-Taybi syndrome Adcy9 schizophrenia Adcy7 , Akap11 , Pde11a , Pde4b sciatic neuropathy Akap12 skin disease Akap9 , Pde4b spermatogenic failure 82 Akap3 Spinal Cord Injuries Adcy3 , Pde4d status epilepticus Glp1r striatal degeneration 2 Pde10a Striatal Degeneration, Autosomal Dominant Pde8b Striatal Degeneration, Autosomal Dominant 1 Pde8b stroke Pde3a , Pde4d substance-related disorder Akap7 , Pde1c Sudden Cardiac Death Akap9 sudden infant death syndrome Akap10 Sudden Unexpected Nocturnal Death Syndrome Akap9 Teratozoospermia Akap4 Tetany Akap5 thrombosis Pde3a transient cerebral ischemia Pde4d traumatic brain injury Pde10a Tremor Prkar1b type 2 diabetes mellitus Adcy5 , Glp1r ulcerative colitis Adcy7 ureteral obstruction Adcy6 Ventricular Fibrillation Akap9 Ventricular Tachycardia Akap9 Weight Gain Pakap withdrawal disorder Adcy1 , Adcy8 Wolff-Parkinson-White syndrome Akap9